Peptides Are Exploding. Payments Isn’t Ready
Peptides Are Exploding. Payments Isn’t Ready. The Research-Peptide Market Is Growing Faster Than the Infrastructure Built to Underwrit...
In a groundbreaking study published this week in the American Journal of Psychiatry, researchers at Brown University have provided some of the strongest evidence yet that cannabis use may significantly reduce alcohol consumption in the short term. The findings arrive at a critical moment as public health officials grapple with both rising cannabis use and alcohol's status as a leading cause of preventable death in the United States.
Led by Dr. Jane Metrik, a professor of behavioral and social science at Brown University, researchers created an elaborate "bar lab" designed to replicate real-world drinking conditions while maintaining scientific rigor. Participants underwent three separate sessions where they smoked marijuana joints of varying potency—high THC, low THC, and a placebo—before spending two hours in a comfortable bar-like setting with access to their preferred alcoholic beverages.
The results were striking. Participants who smoked higher potency cannabis consumed 27% less alcohol compared to the placebo group, while those using lower potency cannabis drank 19% less. Additionally, cannabis users delayed their drinking onset, suggesting a meaningful behavioral shift in consumption patterns.
"It is an important signal that we're detecting," Metrik told NPR. "It is telling us that cannabinoids could play a potential therapeutic role in alcohol use disorder."
The Brown study builds on similar research conducted in Colorado earlier this year, where participants who used cannabis from dispensaries at home showed a 25% reduction in alcohol consumption when tested in a mobile laboratory. According to Dr. Hollis Karoly, who led that study, "These findings are all converging on a similar story."
However, researchers emphasize caution. The approach didn't work uniformly—some participants actually increased their alcohol consumption after using cannabis, highlighting significant individual differences in response to the substances.
While alcohol kills more than 170,000 Americans annually and ranks among the leading causes of preventable death, cannabis carries its own risks. Research has linked marijuana use to cognitive impairment, memory problems, increased psychosis risk, and a serious gastrointestinal syndrome causing severe nausea and vomiting.
"We're not ready to tell people seeking treatment for alcohol, go ahead and substitute cannabis, and it will work out for you," Metrik cautioned. "Once you're in the throes of daily cannabis use, it's very hard to kick that habit."
Most participants in the Brown trial met criteria for cannabis use disorder, and about 40% qualified for alcohol use disorder, raising questions about whether substituting one substance for another simply trades one problem for another.
Despite these concerns, many people are already using cannabis to manage alcohol consumption without professional guidance. "We see this all the time, and we don't know what to tell them," Metrik noted. "There's no clear messaging."
As the cannabis industry continues expanding and consumption patterns evolve, the need for rigorous quality management and compliance monitoring becomes increasingly critical.
In an industry where product safety and regulatory compliance directly impact consumer health outcomes, businesses need robust systems to ensure quality at every step. Qredible's comprehensive quality management solutions help cannabis companies maintain the highest standards through blockchain-secured documentation, automated compliance monitoring, and transparent supply chain management. Whether you're producing cannabis products or operating in other highly regulated sectors, contact Qredible today to learn how our Q-Trust platform can help you build consumer confidence through verified quality and compliance.
